The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1162
August 4, 2003
View Complete Issue         Table of Contents 2019 
Issue 1162
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Over-the-counter Omeprazole (Prilosec OTC)
August 4, 2003 (Issue: 1162)
The FDA recently approved the proton pump inhibitor omeprazole magnesium (Prilosec OTC) for over-the-counter use for treatment of frequent heartburn. It will be marketed in late September or early October. Five proton pump inhibitors, including...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1162
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.